<DOC>
	<DOCNO>NCT02340182</DOCNO>
	<brief_summary>The objective study investigate role gut microbiota systemic priming immune effector cell . Twelve healthy male volunteer , 18-35 year age , treat broad spectrum antibiotic ( ciprofloxacin , vancomycin , metronidazole ) seven day , order deplete gut microbiota . Blood faeces sample , 24 hour 6 week 7-day period antibiotic . Main study endpoint include laboratory parameter inflammatory response , functional assay ( ex vivo stimulation assay ) gut microbiota composition .</brief_summary>
	<brief_title>The Role Microbiota Systemic Immune Response</brief_title>
	<detailed_description>Rationale : Sepsis rank among top ten lead cause death worldwide . Most nonsurvivors die state immunosuppression . The gut microbiota exert numerous beneficial function host response infection . Gut flora component express microorganism-associated molecular pattern ( MAMPs ) lipopolysaccharide ( LPS ) , recognize pattern recognition receptor ( PRRs ) express neutrophils macrophage . MAMPs intestinal microbiota constitutively translocate circulation prime bone marrow derive neutrophil via PRRs . Antibiotic treatment , standard care patient sepsis , deplete gut microbiota lead diminished release MAMPs bacteria derive product . This cause diminished prim systemic immunity , may attribute sepsis associate immunosuppression increase susceptibility invade bacteria . Objective : To investigate role gut microbiota systemic priming immune effector cell Study design : Within-subject-controlled intervention study human volunteer Study population : Twelve healthy male subject , 18-35 year age Intervention : All subject treat broad spectrum antibiotic ( ciprofloxacin , vancomycin , metronidazole ) seven day , order deplete gut microbiota . Blood faeces sample , 24 hour 6 week 7-day period antibiotic . Main study parameters/endpoints : Laboratory parameter inflammatory response , functional assay ( ex vivo stimulation assay ) gut microbiota composition .</detailed_description>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Healthy Male 18 35 year age Capable give write informed consent able comply requirement restriction Chemistry panel without clinically relevant abnormality Normal defecation pattern ( define &lt; 3x/ day &gt; 3x/week ) Major illness past 3 month significant chronic medical illness ; History type malignancy ; Past current gastrointestinal disease may influence gut microbiota ; Known positive test hepatitis C antibody , hepatitis B surface antigen HIV ; Current chronic history liver disease , know hepatic biliary abnormality ; Use tobacco product ; History , within 3 year , drug abuse ; History alcoholism and/or drink 3 unit alcohol per day ; The subject receive investigational product within three month day 1 ; Use prescription nonprescription drug herbal dietary supplement within 6 month ; Recent ( &lt; 12 month ) use antibiotic ( kind , except dermal antibiotic ) ; Allergy antibiotic ( kind ) ; Difficulty swallow pill ; Any relevant issue .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>gut flora</keyword>
	<keyword>antibiotic</keyword>
	<keyword>systemic immune response</keyword>
	<keyword>Volunteers</keyword>
</DOC>